Back HIV/AIDS

HIV / AIDS

IAS 2013: Studies Shed More Light on Male Circumcision for HIV Prevention

Programs offering voluntary medical male circumcision (VMMC) as part of HIV prevention are now starting to expand in a number countries in sub-Saharan Africa, delegates heard at the recent 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013). The conference also heard information about the Shang Ring, one of several new circumcision devices.

alt

IAS 2013: Male Circumcision Using the Shang Ring [VIDEO]

A novel device used in the scale-up of voluntary male circumcision for HIV prevention can cut the time of the procedure in half and was associated with few side effects, but healing may be slower, according to a report presented at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this month in Kuala Lumpur.

alt

IAS 2013: Fem-PrEP Trial May Have Failed Because Participants Used Testing as Prevention

While the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) featured news from 2 trials of pre-exposure prophylaxis (PrEP) that had positive results, it also featured an analysis of the reasons why another trial may have had a negative one.

alt

HIV+ Boy Dies After HIV-resistant Stem Cell Transplant for Leukemia

A 12-year-old HIV positive boy with acute lymphoblastic leukemia died earlier this month due to graft-versus-host disease complications after undergoing an experimental cord blood transplant in April from a donor with the CCR5-delta-32 (CCR5-Δ-32) mutation, which makes cells resistant to HIV entry, the University of Minnesota announced this week.

alt

IAS 2013: Scientists and Clinicians Must Challenge HIV-related Stigma

Scientists should not only create knowledge to improve the HIV epidemic, they also have a duty to speak out about human rights abuses and ensure that access to effective, high quality HIV prevention, care, and treatment programs are unimpeded by laws, stigma, and discrimination, experts in human rights and law asserted at several sessions held during the alt7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this month in Kuala Lumpur.

IAS 2013: PrEP Appears Safe for Use in Conception, But May Not Be Necessary

HIV negative women who wish to become pregnant with their male HIV positive partner can be reassured that pre-exposure prophylaxis (PrEP) appears to be a safe option in terms of maternal and infant outcomes, according to data presented at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this month in Kuala Lumpur. But modeling work suggested that if the woman’s partner is already taking HIV treatment and unprotected sex is limited to her fertile days, then the addition of PrEP may not afford any extra benefit.

alt

IAS 2013: The Future of HIV Cure Research [VIDEO]

Research towards a cure for HIV was a key theme of the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) last month in Kuala Lumpur, as well as a 2-day IAS pre-conference. While hesitant to make firm predictions, experts offered some cautious opinions on the future of cure research.

alt